In vitro study of partially hydrolyzed poly(2-ethyl-2-oxazolines) as materials for biomedical applications

Journal of Materials Science: Materials in Medicine

Volumn 26, Issue 4, 2015, Pages

  Shah, Rushita ^a   Kronekova, Zuzana ^b   Zahoranová, Anna ^b   Roller, Ladislav ^c   Saha, Nabanita ^a   Saha, Petr ^a   Kronek, Juraj ^b  

^a TOMAS BATA UNIVERSITY IN ZLIN   (Czech Republic)

^b POLYMER INSTITUTE   (Slovakia)

^c INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

CATIONIC POLYMERIZATION; CELL CULTURE; CELLS; CYTOLOGY; ETHYLENE; FIBROBLASTS; HYDROLYSIS; LIVING POLYMERIZATION; MACROPHAGES; MAMMALS; MEDICAL APPLICATIONS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

BIOMEDICAL APPLICATIONS; CONFOCAL LASER SCANNING MICROSCOPY; DEGREE OF HYDROLYSIS; H NMR SPECTROSCOPY; LIVING CATIONIC POLYMERIZATION; PARTIALLY HYDROLYZED; POLYMER CONCENTRATIONS; POLYMER HYDROLYSIS;

POLYMERS;

AZIRIDINE; BIOMATERIAL; COPOLYMER; DRUG TOXICITY; OXAZOLINE DERIVATIVE; POLY(2-ETHYL-2-OXAZOLINE); POLY(2ETHYL 2 OXAZOLINE); POLYAMINE; POLYMER; PYRENE; UNCLASSIFIED DRUG;

3T3 CELL LINE; ANIMAL; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL LINE; CELL SURVIVAL; CELL VIABILITY; CHEMICAL STRUCTURE; CHEMISTRY; CONCENTRATION (PARAMETERS); CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG EFFECTS; EMBRYO; FIBROBLAST; HYDROLYSIS; IN VITRO STUDY; MACROPHAGE; MATERIALS TESTING; METABOLISM; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PARTICLE SIZE; POLYMERIZATION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

3T3 CELLS; ANIMALS; BIOCOMPATIBLE MATERIALS; CELL LINE; CELL SURVIVAL; CELLS, CULTURED; CHEMISTRY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EFFECTS; HYDROLYSIS; MATERIALS TESTING; METABOLISM; MICE; POLYAMINES; TOXICITY;

EID: 84938089440     PISSN: 09574530     EISSN: 15734838     Source Type: Journal    
DOI: 10.1007/s10856-015-5485-4     Document Type: Article

References (36)

1. Ballarín-González B, Howard KA. Polycation-based nanoparticle delivery of RNAi therapeutics: adverse effect and solutions. Adv Drug Deliv Rev. 2012;64:1717–29.
2. Davis ME. Nonviral gene delivery systems. Curr Opin Biotechnol. 2002;13:128–31.
3. Segura T, Shea LD. Materials for nonviral gene delivery. Annu Rev Mater Res. 2001;31:25–46.
4. Calafiore R, Basta G. Clinical applications of microencapsulated islets: actual prospectives on progress and challenges. Adv Drug Deliv Rev. 2014;67–68:84–92.
5. Lacík I. Current status in immunoprotection of transplanted islets: focus on Islet micro-encapsulation. Micro and Nano Syst. 2013;5:168–76.
6. Ponce S, Orive G, Hernandez R, Gascon AR, Pedraz JL, De Haan BJ, Faas MM, Mathieu HJ, de Vos P. Chemistry and the biological response against immunoisolating alginate polycation capsules of different composition. Biomaterials. 2006;27:4831–9.
7. Balan V, Verestiuc L. Strategies to improve chitosan hemocompatibility: a review. Eur Polym J. 2014;53:171–88.
8. Zhong D, Jiao Y, Zhang Y, Zhang W, Li N, Zuo Q. Effects of the gene carrier polyethylene imines on structure and function of blood components. Biomaterials. 2013;34:294–305.
9. Kronek J, Paulovicova E, Paulovicova L, Kronekova Z, Luston J. Biocompatibility and immunocompatibility assessment of poly(2-oxazolines). In Practical applications in Biomedical engineering. Rijeka: InTech; 2012. p. 257–84.
10. Kronek J, Kronekova Z, Luston J, Paulovicova E, Paulovicova L, Mendrek B. In vitro bio-immunological and cytotoxicity studies of poly(2-oxazolines). J Mater Sci Mater Med. 2011;22:1725–34.
11. Hoogenboom R, Fijten MWM, Michael AR, Meier MAR, Schubert US. Living cationic polymerizations utilizing an automated synthesizer: high-throughput synthesis of polyoxazolines. Macromol Rapid Commun. 2003;24:92–7.
12. Hoogenboom R, Fijten MWM, Schubert US. Parallel kinetic investigation of 2-oxazoline polymerizations with different initiators as basis for designed copolymer synthesis. J Polym Sci. 2004;42:1830–40.
13. Kronek J, Luston J, Kronekova Z, Paulovicova E, Farkas P, Petrencikova N, Paulovicova L, Janigova I. Synthesis and bioimmunological efficiency of poly(2-oxazolines) containing a free amino group. J Mater Sci Mater Med. 2010;21:879–86.
14. Dworak A, Trzebicka B, Kowalczuk A, Tsvetanov C, Rangelov S. Polyoxazolines-mechanism of synthesis and solution properties. Polimery. 2014;59:88–94.
15. Luxenhofer R, Sahay G, Schulz A, Alakhova D, Bronich TK, Jordan R, Kabanov AV. Structure-property relationship in cytotoxicity and cell uptake of poly(2-oxazoline) amphiphiles. J Control Rel. 2011;153:73–82.
16. Luxenhofer R, Han Y, Schulz A, Tong J, He Z, Kabanov AV, Jordan R. Poly(2-oxazoline)s as polymer therapeutics. Macromol Rapid Commun. 2012;33:1613–31.
17. Adams N, Schubert US. Poly(2-oxazolines) in Biological and Biomedical Application Contexts. Adv Drug Deliv Rev. 2007;59:1504–20.
18. Uyama H, Kobayashi S. Synthesis of poly(2-oxazoline) macromonomers having a vinyl ester group. Macromolecules. 1991;24:614–5.
19. Celebi O. Synthesis and Characterization of Poly(2-Ethyl-2-Oxazoline) Functional Prepolymers and Block Copolymers. Dissertation thesis. URI: http://hdl.handle.net/10919/24908 Jan 19 2014.
20. Hoogenboom R. Poly(2-oxazoline)s: a polymer class with numerous potential applications. Angew Chem Int Ed. 2009;48:7978–94.
21. Hoogenboom R, Schlaad H. Bioinspired poly(2-oxazoline)s. Polymers. 2011;3:467–88.
22. Van Kuringen HPC, Lenoir J, Adriens E, Bender J, Geest BGD, Hoogenboom R. Partial hydrolysis of poly(2-ethyl-2-oxazoline) and potential implications for biomedical applications. Macromol Biosci. 2012;12:1114–23.
23. Van Kuringen HPC, De la Rosa VR, Fijten MWM, Heuts JPA, Hoogenboom R. Enhanced selectivity for the hydrolysis of block copoly(2-oxazoline)s in ethanol-water resulting in linear poly(ethylene imine) copolymers. Macromol Rapid Commun. 2012;33:827–32.
24. Lin PC, Sung CY, Hsiue HG. Non-viral pH sensitive Gene carriers based on poly(2-ethyl-2-oxazolines)-co-ethyleneimine-block-poly(2-ethyl-2-oxazolines)-co-ethyleneimine: A study of gene release behavior. J Med Biol Eng. 2012; 365–372.
25. Englert C, Tauhardt L, Hartlieb M, Kempe K, Gottschaldt M, Schubert US. Linear poly(ethylene imine)-based hydrogels for effective binding and release of DNA. Biomacromolecules. 2014;15:1124–31.
26. Hong S, Leroueil PR, Janus EK, Peters JL, Kober MM, Islam MT, Orr BG, Baker Jr, Banaszak Holl MM. Interaction of polycationic polymers with supported lipid bilayers and cells: nanoscale hole formation and enhanced membrane permeability. Bioconjugate Chem. 2006;17:728–34.
27. Rokstad AM, Strand B, Espevik T, Mollnes TE. Biocompatibility and biotolerability assessment of microspheres using a whole blood model. Micro and Nano Syst. 2013;5:177–85.
28. Sohaebuddin SK, Thevenot PT, Baker D, Easton JW, Tang L. Nanomaterial cytotoxicity is composition, size, and cell type dependent. Particle Fibre Toxicol. 2010;7:22.
29. Sherratt JA, Dallon JC. Theoretical models of wound healing: past successes and future challenges. Comptes Rendus Biol. 2002;325:557–64.
30. Hunt NC, Shelton RM, Henderson DJ, Grover LM. Calcium-alginate hydrogel-encapsulated fibroblasts provide sustained release of vascular endothelial growth factor. Tissue Eng A. 2013;19:905–14.
31. Todaro GJ, Green H. Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J Cell Biol. 1963;17:299–313.
32. Moore C, Cooper GJS. Co-secretion of amylin and insulin from cultured islet β-cells: modulation by nutrient secretagogues, islet hormones and hypoglycemic agents. Biochem Biophys Res Commun. 1991;179:1–9.
33. Efrat S, Linde S, Kofod H, Spector D, Delannoy M, Grant S, Hanahan D, Baekkeskov S. Beta-cell lines derived from transgenic mice expressing a hybrid insulin gene-oncogene. Proc Nat Acad Sci USA. 1988;85:9037–41.
34. Kronek J, Paulovičova E, Paulovičova L, Kronekova Z, Lustoň J. Immunomodulatory efficiency of poly(2-oxazolines). J Mater Sci Mater Med. 2012;23:1457–64.
35. Fernandes JC, Qiu X, Winnik FM, Benderdour M, Zhang X, Dai K, Shi Q. Linear polyethylenimine produced by partial acid hydrolysis of poly(2-ethyl-2-oxazoline) for DNA and siRNA delivery in vitro. Int J Nanomed. 2013;8:4091–102.
36. Howard KA. Delivery of RNA interference therapeutics using polycation-based nanoparticles. Adv Drug Deliv Rev. 2009;61:710–20.